Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Marco Tuccori, Irma Convertino, Maria Teresa Galiulo, Alessandra Marino, Alice Capogrosso-Sansone & Corrado Blandizzi. (2017) Diabetes drugs and the incidence of solid cancers: a survey of the current evidence. Expert Opinion on Drug Safety 16:10, pages 1133-1148.
Read now
Read now
Jennifer N. Clements, Heather P. Whitley, Jennifer J. D’Souza, Benjamin Gross, Rick Hess, Sara Reece, Chad Gentry & Kayce Shealy. (2015) Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: an opinion paper from the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy. Current Medical Research and Opinion 31:9, pages 1733-1741.
Read now
Read now
Erin K. Buysman, Wing Chow, Henry J. Henk & Marcia F.T. Rupnow. (2015) Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting. Current Medical Research and Opinion 31:1, pages 137-143.
Read now
Read now
Yukio Tanizawa, Kohei Kaku, Eiichi Araki, Kazuyuki Tobe, Yasuo Terauchi, Kazunori Utsunomiya, Yasuhiko Iwamoto, Hirotaka Watada, Wataru Ohtsuka, Daisuke Watanabe & Hideki Suganami. (2014) Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials. Expert Opinion on Pharmacotherapy 15:6, pages 749-766.
Read now
Read now
Chin-Hsiao Tseng. (2014) A Review on Thiazolidinediones and Bladder Cancer in Human Studies. Journal of Environmental Science and Health, Part C 32:1, pages 1-45.
Read now
Read now
Luke D Boyle & John PH Wilding. (2013) Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes. Expert Opinion on Emerging Drugs 18:3, pages 375-391.
Read now
Read now
Julia Kenkre, Tricia Tan & Stephen Bloom. (2013) Treating the obese diabetic. Expert Review of Clinical Pharmacology 6:2, pages 171-183.
Read now
Read now
Articles from other publishers (7)
Nanjing Shi, Yetan Shi, Jingsi Xu, Yuexiu Si, Tong Yang, Mengting Zhang, Derry Minyao Ng, Xiangyuan Li & Fei Xie. (2021) SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Frontiers in Public Health 9.
Crossref
Crossref
Şazi İMAMOĞLU. (2021) Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus. Turkish Journal of Internal Medicine 3:1, pages 1-5.
Crossref
Crossref
Мaryana М. Rоsul, Мiroslava М. Bletskan, Nataliya V. Ivano, Marina O. Korabelschykova & Yelyzaveta І. Rubtsova. (2020) PRIORITIES OF ANTI-HYPERGLYCAEMIC DRUG THERAPY IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE. Wiadomości Lekarskie 73:3, pages 609-613.
Crossref
Crossref
Shinji Kamei, Masahiro Iwamoto, Miyuki Kameyama, Masashi Shimoda, Tomoe Kinoshita, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Fuminori Tatsumi, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku & Hideaki Kaneto. (2018) Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus. Journal of Diabetes Research 2018, pages 1-6.
Crossref
Crossref
Takuo Yoshimoto, Takayuki Furuki, Hiroyuki Kobori, Masaaki Miyakawa, Hitomi Imachi, Koji Murao & Akira Nishiyama. (2023) Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Urinary Excretion of Intact and Total Angiotensinogen in Patients with Type 2 Diabetes. Journal of Investigative Medicine 65:7, pages 1057-1061.
Crossref
Crossref
Rajesh Peter, Hammad Bajwa & Sony Anthony. (2013) Hyperlipidaemia and cardiovascular disease – Newer antihyperglycaemic agents and cardiovascular disease. Current Opinion in Lipidology 24:2, pages 189-190.
Crossref
Crossref
Toshiro Sugimoto & Atsunori Kashiwagi. (2013) Novel Therapeutic Agents for the Treatment of Diabetes Sodium-glucose Co-transporter (SGLT) 2 Inhibitors糖尿病における新規治療薬SGLT阻害薬. Nihon Naika Gakkai Zasshi 102:6, pages 1474-1483.
Crossref
Crossref